These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 22191030)
1. On the use of molecular weight cutoff cassettes to measure dynamic relaxivity of novel gadolinium contrast agents: example using hyaluronic Acid polymer complexes in phosphate-buffered saline. Kasraie N; Oviatt HW; Clarke GD Radiol Res Pract; 2011; 2011():808795. PubMed ID: 22191030 [TBL] [Abstract][Full Text] [Related]
2. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049 [TBL] [Abstract][Full Text] [Related]
4. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549 [TBL] [Abstract][Full Text] [Related]
5. Gadolinium-Labeled Biodegradable Dendron-Hyaluronic Acid Hybrid and Its Subsequent Application as a Safe and Efficient Magnetic Resonance Imaging Contrast Agent. Guo C; Sun L; Cai H; Duan Z; Zhang S; Gong Q; Luo K; Gu Z ACS Appl Mater Interfaces; 2017 Jul; 9(28):23508-23519. PubMed ID: 28656751 [TBL] [Abstract][Full Text] [Related]
6. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents. McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin. Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062 [TBL] [Abstract][Full Text] [Related]
8. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903 [TBL] [Abstract][Full Text] [Related]
9. Dissociation kinetics of open-chain and macrocyclic gadolinium(III)-aminopolycarboxylate complexes related to magnetic resonance imaging: catalytic effect of endogenous ligands. Baranyai Z; Pálinkás Z; Uggeri F; Maiocchi A; Aime S; Brücher E Chemistry; 2012 Dec; 18(51):16426-35. PubMed ID: 23139193 [TBL] [Abstract][Full Text] [Related]
10. Stability constants and 1H relaxation effects of ternary complexes formed between Gd-DTPA, Gd-DTPA-BMA, Gd-DOTA, and Gd-EDTA and citrate, phosphate, and carbonate ions. Burai L; Hietapelto V; Király R; Tóth E; Brücher E Magn Reson Med; 1997 Jul; 38(1):146-50. PubMed ID: 9211390 [TBL] [Abstract][Full Text] [Related]
11. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy. Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321 [TBL] [Abstract][Full Text] [Related]
12. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T. Reichenbach JR; Hackländer T; Harth T; Hofer M; Rassek M; Mödder U Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129 [TBL] [Abstract][Full Text] [Related]
13. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Donahue KM; Burstein D; Manning WJ; Gray ML Magn Reson Med; 1994 Jul; 32(1):66-76. PubMed ID: 8084239 [TBL] [Abstract][Full Text] [Related]
14. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
15. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates? Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand. Pálinkás Z; Baranyai Z; Brücher E; Rózsa B Inorg Chem; 2011 Apr; 50(8):3471-8. PubMed ID: 21405037 [TBL] [Abstract][Full Text] [Related]
17. Gadodiamide T1 relaxivity in brain tissue in vivo is lower than in saline. Pickup S; Wood AK; Kundel HL Magn Reson Med; 2005 Jan; 53(1):35-40. PubMed ID: 15690500 [TBL] [Abstract][Full Text] [Related]
19. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging. Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614 [TBL] [Abstract][Full Text] [Related]
20. [Synthesis, characterization and relaxivity of dimeric DTPA-gadonium (III) complexes with long chain alkyl esters of L-lysine]. Yu KC; Liu LY; Wan FX; Zhou JL; Ding SW; Ye CH Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Apr; 26(4):670-3. PubMed ID: 16836136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]